Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Addison

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|March 23, 2022
VIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft modelsVictoria Allen, Josée Coulombe, Huijun Zhao, et al.
Journal of Bone Oncology|February 25, 2016
Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient surveyBrian Hutton, Patricia Morretto, Urban Emmenegger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activityC L Addison, T O Daniel, M D Burdick, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 17, 2001
Engineering and characterization of functional human microvessels in immunodeficient miceJ E Nör, M C Peters, J B Christensen, et al.
Molecular and Cellular Biology|October 13, 2006
Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stressJaime D Blais, Christina L Addison, Robert Edge, et al.
Clinical Lung Cancer|June 18, 2015
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24Jair Bar, Keyue Ding, Huijun Zhao, et al.
Journal of Bone Oncology|December 24, 2016
A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancerC L Addison, D Simos, Z Wang, et al.
Bone Reports|November 29, 2021
Histomorphometric and microarchitectural analysis of bone in metastatic breast cancer patientsA Beltran-Bless, M Murshed, M Zakikhani, et al.
Plos One|March 11, 2016
Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung CancerGrant A Howe, Bin Xiao, Huijun Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology GroupScott A Laurie, Desiree Hao, Natasha B Leighl, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|March 23, 2022
VIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft modelsVictoria Allen, Josée Coulombe, Huijun Zhao, et al.
Journal of Bone Oncology|February 25, 2016
Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient surveyBrian Hutton, Patricia Morretto, Urban Emmenegger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activityC L Addison, T O Daniel, M D Burdick, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 17, 2001
Engineering and characterization of functional human microvessels in immunodeficient miceJ E Nör, M C Peters, J B Christensen, et al.
Molecular and Cellular Biology|October 13, 2006
Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stressJaime D Blais, Christina L Addison, Robert Edge, et al.
Clinical Lung Cancer|June 18, 2015
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24Jair Bar, Keyue Ding, Huijun Zhao, et al.
Journal of Bone Oncology|December 24, 2016
A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancerC L Addison, D Simos, Z Wang, et al.
Bone Reports|November 29, 2021
Histomorphometric and microarchitectural analysis of bone in metastatic breast cancer patientsA Beltran-Bless, M Murshed, M Zakikhani, et al.
Plos One|March 11, 2016
Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung CancerGrant A Howe, Bin Xiao, Huijun Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology GroupScott A Laurie, Desiree Hao, Natasha B Leighl, et al.
Pageof 15